XML 38 R29.htm IDEA: XBRL DOCUMENT v3.22.1
Fair Value Measurements (Tables)
3 Months Ended
Mar. 31, 2022
Fair Value Measurements  
Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis

Assets and liabilities measured at fair value are summarized below:

 

   Total Fair Value   Quoted Prices in Active Markets for Identical Assets/Liabilities (Level 1)  

Significant Other Observable Inputs

(Level 2)

  

Significant Unobservable Inputs

(Level 3)

 
Assets:                    
                     
Recurring items as of March 31, 2022                    
Corporate debt securities, available for sale  $12,943,814   $   $   $12,943,814 
                     
Non-recurring items as of March 31, 2022                    
In-process R&D (Note 9)  $13,366,234   $   $   $13,366,234 
                     
Recurring items as of December 31, 2021                    
Corporate debt securities, available for sale  $29,803,095   $   $   $29,803,095 
                     
Non-recurring items as of December 31, 2021                    
In-process R&D (Note 9)  $13,366,234   $   $   $13,366,234 
                     
Liabilities:                    
                     
Recurring items as of March 31, 2022                    
Earn-out milestone liability (Note 14)  $5,396,000   $   $   $5,396,000 
                     
Recurring items as of December 31, 2021                    
Earn-out milestone liability (Note 14)  $5,396,000   $   $   $5,396,000